Search by Drug Name or NDC
NDC 53746-0590-01 Calcium Acetate 667 mg/1 Details
Calcium Acetate 667 mg/1
Calcium Acetate is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals of New York LLC. The primary component is CALCIUM ACETATE.
MedlinePlus Drug Summary
Calcium acetate is used to control high blood levels of phosphorus in people with kidney disease who are on dialysis (medical treatment to clean the blood when the kidneys are not working properly). Calcium acetate is in a class of medications called phosphate binders. It binds phosphorus that you get from foods in your diet and prevents it from being absorbed into your blood stream.
Related Packages: 53746-0590-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Calcium Acetate
Product Information
NDC | 53746-0590 |
---|---|
Product ID | 53746-590_4daaf871-3ef0-4dea-b140-e67573ea5e9b |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Calcium Acetate |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Calcium Acetate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE |
Route | ORAL |
Active Ingredient Strength | 667 |
Active Ingredient Units | mg/1 |
Substance Name | CALCIUM ACETATE |
Labeler Name | Amneal Pharmaceuticals of New York LLC |
Pharmaceutical Class | Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA201658 |
Listing Certified Through | 2024-12-31 |
Package
NDC 53746-0590-01 (53746059001)
NDC Package Code | 53746-590-01 |
---|---|
Billing NDC | 53746059001 |
Package | 100 CAPSULE in 1 BOTTLE (53746-590-01) |
Marketing Start Date | 2014-10-08 |
NDC Exclude Flag | N |
Pricing Information | N/A |